Cadrenal Therapeutics Inc (CVKD)

Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	38.91% 1.7556	1.2638	1.1426	1.0262	4.2002
Operating Income/Loss	38.91% -1.7556	-1.2638	-1.1426	-1.0262	-4.2002
Nonoperating Income/Loss	22.91% 0.0923	0.1198	0.1061	0.0232	-0.9733
Income/Loss From Continuing Operations Before Tax	45.38% -1.6633	-1.1441	-1.0365	-1.003	-5.1736
Income/Loss From Continuing Operations After Tax	45.38% -1.6633	-1.1441	-1.0365	-1.003	-5.1736
Net Income/Loss	45.38% -1.6633	-1.1441	-1.0365	-1.003	-5.1736
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-1.003	-5.1736
Basic Average Shares	1,781% 16.01	0.8512	15.40	11.72	10.77
Diluted Average Shares	1,781% 16.01	0.8512	15.40	11.72	10.77
Basic Earnings Per Share	100.00% -0.10	-0.05	-0.07	-0.09	-0.48
Diluted Earnings Per Share	100.00% -0.10	-0.05	-0.07	-0.09	-0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-